trending Market Intelligence /marketintelligence/en/news-insights/trending/rramdwna46ivi6zvdqgfhw2 content esgSubNav
In This List

Recipharm CFO to transition to another company

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Recipharm CFO to transition to another company

Recipharm AB CFO Henrik Stenqvist is moving to Swedish Orphan Biovitrum AB to serve in the same capacity.

Stenqvist resigned as CFO of Recipharm, continuing his duties until later in the spring, the Stockholm-based drugmaker said in a news release.

The company has initiated a search process for Stenqvist's replacement.

Swedish Orphan said Stenqvist will join the Solna, Sweden-based biopharmaceutical company in late spring.

Current Swedish Orphan CFO Mats-Olof Wallin will support the transition process and will retire by 2018-end.